Ghayas C. Issa

Statistics

Publications

110

Citations

6.3K

H-Index

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Washington University in St. Louis

University of Chicago

Memorial Sloan Kettering Cancer Center

Albert Einstein College of Medicine

Ghayas C. Issa is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

ORCID

Publications per year

2016–2025

110

Publications

110

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio et al. · Nature · 2023 · 468 citations · Full text

Medicine, Molecular Biology, Oncology +13

Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia

Courtney D. DiNardo, Curtis A. Lachowiez, Koichi Takahashi et al. · Journal of Clinical Oncology · 2021 · 334 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

Courtney D. DiNardo, Abhishek Maiti, Caitlin R. Rausch et al. · The Lancet Haematology · 2020 · 331 citations · Full text

Medicine, Hematology, Oncology +16

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Nicholas J. Short, Elias Jabbour, Koji Sasaki et al. · Blood · 2016 · 253 citations · Full text

Medicine, Hematology, Oncology +12

Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour, Nicholas J. Short, Nitin Jain et al. · The Lancet Haematology · 2022 · 239 citations

Medicine, Hematology, Oncology +12

1–5 of 110